Skip to main content
Premium Trial:

Request an Annual Quote

Cyntellect Wins $1.5M Phase II SBIR Grant to Continue Developing Applications for LEAP Technology

NEW YORK, Sept. 14 (GenomeWeb News) - Cyntellect has received around $1.5 million in a Phase II Small Business Innovative Research grant to continue developing RNA interference applications on its LEAP platform, the company said today.


Specifically, the money will help the privately held company pay for further development of its LEAP-enabled LaserFect technology for high-efficiency, low-toxicity delivery of siRNA into cells "that are typically refractory to standard transfection techniques."


The award comes 10 months after Cyntellect won $500,000 in a Phase II SBIR grant to develop the laser-based transfection technology, and the fifth the company has received since July 2003, RNAi News, GenomeWeb News' sister publication, reported in November.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.